Advanced unresectable Urothelial Cancer – GSK – IQVIA EPON

People with Urothelial Cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have Histologically confirmed locally advanced or metastatic or locally advanced/unresectable urothelial carcinoma
  • Able to provide, a tumor tissue sample

You may NOT participate in this study if you:

  • Have active brain and/or leptomeningeal disease
  • Have history of malignancy other than urothelial cancer within the last 3 years
  • Have cirrhosis or current unstable liver or biliary disease
  • Have an active infection
  • Have a history of bleeding diathesis
  • Have known immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C
  • Are pregnant or breastfeeding

Contact Information
Philip Garcia, Clinical Research Coordinator
1 Gustave Levy Place Box 1128
New York, NY 10029
Phone: (212) 824-7312